Advert - Sanofi – AUTH/3402/10/20

• Date posted
  02 August 2021
• Sanction
  Advertisement,
• Case number/s
  AUTH/3402/10/20 - Complainant v Sanofi

For a product website which contained inaccurate information about, and out of date prescribing information for Dupixent (dupilumab), Sanofi was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 3.2 - Promotion inconsistent with the summary of product characteristics

Clause 7.2 - Making a misleading statement

Clause 9.1 - Failing to maintain high standards